Minimally invasive versus conventional sternotomy for Mitral valve repair: protocol for a multicentre randomised controlled trial (UK Mini Mitral).

Rebecca H Maier ORCID logo ; Adetayo S Kasim ORCID logo ; Joseph Zacharias ; Luke Vale ORCID logo ; Richard Graham ; Antony Walker ; Grzegorz Laskawski ; Ranjit Deshpande ; Andrew Goodwin ; Simon Kendall ; +23 more... Gavin J Murphy ORCID logo ; Vipin Zamvar ORCID logo ; Renzo Pessotto ; Clinton Lloyd ; Malcolm Dalrymple-Hay ; Roberto Casula ; Hunaid A Vohra ; Franco Ciulli ; Massimo Caputo ORCID logo ; Serban Stoica ; Max Baghai ; Gunaratnam Niranjan ; Prakash P Punjabi ; Olaf Wendler ; Leanne Marsay ; Cristina Fernandez-Garcia ORCID logo ; Paul Modi ; Bilal H Kirmani ; Mark D Pullan ; Andrew D Muir ; Dimitrios Pousios ; Helen C Hancock ORCID logo ; Enoch Akowuah ORCID logo ; (2021) Minimally invasive versus conventional sternotomy for Mitral valve repair: protocol for a multicentre randomised controlled trial (UK Mini Mitral). BMJ open, 11 (4). e047676-. ISSN 2044-6055 DOI: 10.1136/bmjopen-2020-047676
Copy

INTRODUCTION: Numbers of patients undergoing mitral valve repair (MVr) surgery for severe mitral regurgitation have grown and will continue to rise. MVr is routinely performed via median sternotomy; however, there is a move towards less invasive surgical approaches.There is debate within the clinical and National Health Service (NHS) commissioning community about widespread adoption of minimally invasive MVr surgery in the absence of robust research evidence; implementation requires investment in staff and infrastructure.The UK Mini Mitral trial will provide definitive evidence comparing patient, NHS and clinical outcomes in adult patients undergoing MVr surgery. It will establish the best surgical approach for MVr, setting a standard against which emerging percutaneous techniques can be measured. Findings will inform optimisation of cost-effective practice. METHODS AND ANALYSIS: UK Mini Mitral is a multicentre, expertise based randomised controlled trial of minimally invasive thoracoscopically guided right minithoracotomy versus conventional sternotomy for MVr. The trial is taking place in NHS cardiothoracic centres in the UK with established minimally invasive mitral valve surgery programmes. In each centre, consenting and eligible patients are randomised to receive surgery performed by consultant surgeons who meet protocol-defined surgical expertise criteria. Patients are followed for 1 year, and consent to longer term follow-up.Primary outcome is physical functioning 12 weeks following surgery, measured by change in Short Form Health Survey (SF-36v2) physical functioning scale. Early and 1 year echo data will be reported by a core laboratory. Estimates of key clinical and health economic outcomes will be reported up to 5 years.The primary economic outcome is cost effectiveness, measured as incremental cost per quality-adjusted life year gained over 52 weeks following index surgery. ETHICS AND DISSEMINATION: A favourable opinion was given by Wales REC 6 (16/WA/0156). Trial findings will be disseminated to patients, clinicians, commissioning groups and through peer reviewed publication. TRIAL REGISTRATION NUMBER: ISRCTN13930454.


picture_as_pdf
Maier-etal-2021-Minimally-invasive-versus-conventional-sternotomy-for-Mitral-valve-repair-protocol-for-a-multicentre-randomised-controlled-trial-UK-Mini-Mitral.pdf
subject
Published Version
Available under Creative Commons: Attribution 4.0

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads